IDEAYA Enters License Deal With Hengrui Pharma To Develop SHR-4849 Worldwide Outside Of GreaterChina
IDEAYA Biosciences, Inc. (IDYA), a leader in precision medicine oncology, has announced a strategic agreement with Jiangsu Hengrui Pharmaceu...
Showing posts with label IDEAYA Enters License Deal With Hengrui Pharma To Develop SHR-4849 Worldwide Outside Of GreaterChina. Show all posts
Showing posts with label IDEAYA Enters License Deal With Hengrui Pharma To Develop SHR-4849 Worldwide Outside Of GreaterChina. Show all posts
Sunday, December 29, 2024
Posts
Posts